MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Paying Out A Larger Dividend Than Last Year

Published on 5 Apr 2023 on Simply Wall St. via Yahoo Finance

MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) Is Paying Out A Larger Dividend Than Last Year

The board of MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) has announced that it will be paying its dividend of €2.20 on the 4th of May, an increased payment from last year's comparable dividend. Even though the dividend went up, the yield is still quite low at only 1.3%.

Check out our latest analysis for MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien's Earnings Easily Cover The Distributions

Read the rest of the article

PAR.MRK price evolution

XETRA.MRK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist

For those looking for great candidates, here are two in the healthcare sector: Merck (NYSE: MRK) ...

Motley Fool · via Yahoo Finance 21 Nov 2024

Keytruda represents almost half of Merck’s sales, and a new formulation could...

A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stag...

Pharma Voice · via Yahoo Finance 21 Nov 2024

Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s...

We recently published a list of Ken Griffin Stock Portfolio: 10 Stocks to Buy. In this article, w...

Insider Monkey · via Yahoo Finance 20 Nov 2024

J&J, Merck Cut Jobs in China as Local Competition Takes Toll

Johnson & Johnson and Merck & Co. are cutting jobs in China, as they face growing competition fro...

Bloomberg 20 Nov 2024

Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin...

On Tuesday, Merck & Co Inc (NYSE:MRK) revealed topline results from the pivotal Phase 3 MK-3475A-...

Benzinga · via Yahoo Finance 19 Nov 2024

Merck’s Cancer Shot Works. Its Post-Keytruda Plans Are Shaping Up Again.

Merck reported good news Tuesday on a more convenient version of its cancer drug Keytruda, a...

Barrons.com 19 Nov 2024

Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda -...

Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is...

MedCity News 19 Nov 2024

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this...

Insider Monkey · via Yahoo Finance 18 Nov 2024

Is Merck & Co., Inc. (MRK) the Best Immunotherapy Stock to Buy Now?

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Nov 2024

Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Merck & Co.’s recent $1.3 billion deal to reel in Modifi Biosciences seemed to ignore pharma’s...

Pharma Voice · via Yahoo Finance 18 Nov 2024